Literature for TMC-95 (XT01.001 inhibitor)

(Topics flags: S Structure, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2016
1. Wilson,D.L., Meininger,I., Strater,Z., Steiner,S., Tomlin,F., Wu,J., Jamali,H., Krappmann,D. and Gotz,M.G.
   Synthesis and evaluation of macrocyclic peptide aldehydes as potent and selective inhibitors of the 20S proteasome
   ACS Med Chem Lett7, 250-255. PubMed  Europe PubMed DOI  I
2015
2. Xu,K., Wang,K., Yang,Y., Yan,D.A., Huang,L., Chen,C.H. and Xiao,Z.
   Discovery of novel non-covalent inhibitors selective to the beta5-subunit of the human 20S proteasome
   Eur J Med Chem98, 61-68. PubMed  Europe PubMed DOI  I
2013
3. Desvergne,A., Genin,E., Marechal,X., Gallastegui,N., Dufau,L., Richy,N., Groll,M., Vidal,J. and Reboud-Ravaux,M.
   Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome
   J Med Chem56, 3367-3378. PubMed  Europe PubMed DOI  I
2010
4. Groll,M., Gallastegui,N., Marechal,X., Le Ravalec,V., Basse,N., Richy,N., Genin,E., Huber,R., Moroder,L., Vidal,J. and Reboud-Ravaux,M.
   20S Proteasome inhibition: designing noncovalent linear peptide mimics of the natural product TMC-95A
   ChemMedChem5, 1701-1705. PubMed  Europe PubMed DOI  I
2006
5. Groll,M., Gotz,M., Kaiser,M., Weyher,E. and Moroder,L.
   TMC-95-Based inhibitor design provides evidence for the catalytic versatility of the proteasome
   Chem Biol13, 607-614. PubMed  Europe PubMed DOI  I
2004
6. [YEAR:29-11-2004]Groll,M. and Huber,R.
   Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach
   Biochim Biophys Acta1695, 33-44. PubMed  Europe PubMed DOI  V  I
7. [YEAR:9-2-2004]Inoue,M., Zhai,H., Sakazaki,H., Furuyama,H., Fukuyama,Y. and Hirama,M.
   TMC-95A, a reversible proteasome inhibitor, induces neurite outgrowth in PC12 cells
   Bioorg Med Chem Lett14, 663-665. PubMed  Europe PubMed DOI  I
8. Kaiser,M., Milbradt,A.G., Siciliano,C., Assfalg-Machleidt,I., Machleidt,W., Groll,M., Renner,C. and Moroder,L.
   TMC-95A analogues with endocyclic biphenyl ether group as proteasome inhibitors
   Chem Biodivers1, 161-173. PubMed  Europe PubMed DOI  I
9. [YEAR:6-9-2004]Kaiser,M., Groll,M., Siciliano,C., Assfalg-Machleidt,I., Weyher,E., Kohno,J., Milbradt,A.G., Renner,C., Huber,R. and Moroder,L.
   Binding mode of TMC-95A analogues to eukaryotic 20S proteasome
   Chembiochem5, 1256-1266. PubMed  Europe PubMed DOI  S  I
2001
10. [YEAR:17-8-2001]Groll,M., Koguchi,Y., Huber,R. and Kohno,J.
    Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor
    J Mol Biol311, 543-548. PubMed  Europe PubMed DOI  S  I
2000
11. Koguchi,Y., Kohno,J., Nishio,M., Takahashi,K., Okuda,T., Ohnuki,T. and Komatsubara,S.
    TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities
    J Antibiot (Tokyo)53, 105-109. PubMed  Europe PubMed  I